𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

✍ Scribed by Mario E. Lacouture; Milan J. Anadkat; René-Jean Bensadoun; Jane Bryce; Alexandre Chan; Joel B. Epstein; Beth Eaby-Sandy; Barbara A. Murphy; MASCC Skin Toxicity Study Group


Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
476 KB
Volume
19
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Updated clinical practice guidelines for
✍ Dorothy M. Keefe; Mark M. Schubert; Linda S. Elting; Stephen T. Sonis; Joel B. E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Abstract Considerable progress in research and clinical application has been made since the original guidelines for managing mucositis in cancer patients were published in 2004, and the first active drug for the prevention and treatment of this condition has been approved by the United States Fo

Clinical practice guidelines for the pre
✍ Edward B. Rubenstein; Douglas E. Peterson; Mark Schubert; Dorothy Keefe; Deborah 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

## BACKGROUND. Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, 80% of patients with malignancies of the head and neck receiving radiotherapy, and a wide range of patients receiving chemotherap